
Explore how targeted therapies and immunotherapies transform oncology, highlighting novel antibody treatments and their impact on patient care and outcomes.

Michael J. Hennessy Jr is the chairman and CEO of MJH Life Sciences.

Explore how targeted therapies and immunotherapies transform oncology, highlighting novel antibody treatments and their impact on patient care and outcomes.






Pharmacies enhance public health by providing essential back-to-school vaccinations and addressing vaccine hesitancy, ensuring community protection this fall.

Pharmacy deserts challenge access to essential medications, but innovative solutions like telepharmacy and mobile units empower pharmacists to bridge the gap.















The treatment landscape for multiple myeloma continues to evolve.




The authors of these peer -reviewed papers collectively emphasize the evolving landscape of oncology treatment.


MJH Life Sciences is celebrating its 25th anniversary.
